Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Intelligent Bio Solutions Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- −5 vs. Q4 2022
- Shares held
- 226.2K
- −150.5K (−39.9%) vs. Q4 2022
- Total value
- $650.9K
- +$575.7K (+766.3%) vs. Q4 2022
- New holders
- 2
- 1 more added
- Sold out
- 7
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INBS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $416.2K |
| Q1 2026 | 9 | $696.9K |
| Q4 2025 | 7 | $53.0K |
| Q3 2025 | 12 | $1.38M |
| Q2 2025 | 9 | $1.22M |
| Q1 2025 | 9 | $1.26M |
| Q4 2024 | 8 | $107.5K |
| Q3 2024 | 8 | $436.7K |
| Q2 2024 | 8 | $605.8K |
| Q1 2024 | 14 | $2.52M |
| Q4 2023 | 8 | $151.3K |
| Q3 2023 | 4 | $24.3K |
| Q2 2023 | 2 | $8.45K |
| Q1 2023 | 5 | $650.9K |
| Q4 2022 | 10 | $75.1K |
| Q3 2022 | 10 | $799.0K |
| Q2 2022 | 13 | $272.0K |
| Q1 2022 | 14 | $416.0K |
| Q4 2021 | 9 | $347.0K |
| Q3 2021 | 10 | $868.0K |
| Q2 2021 | 12 | $3.36M |
| Q1 2021 | 7 | $291.0K |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Intelligent Bio Solutions Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 126,650 | $367.3K | 1.37% | +126,650 | New |
| Walleye Capital LLC | 96,068 | $273.8K | 0.01% | +96,068 | New |
| Tower Research Capital LLC (TRC) | 2,889 | $8.00K | 0.00% | +2,067+251.5% | Added |
| UBS Group AG | 613 | $1.78K | 0.00% | −10,143−94.3% | Reduced |
| Wells Fargo & Company | 6 | $17 | 0.00% | −87−93.5% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −115,363−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −104,800−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −69,481−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −34,115−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −16,916−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −13,145−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,202−100.0% | Sold out |